Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Clinical trial NCT03982173 · WITHDRAWN

Trial details

NCT number: NCT03982173
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Triple Negative Breast Cancer Prostate Adenocarcinoma Stomach Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2020-09-01
Primary completion: 2024-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.